# Effect of Citicoline/Homotaurine on PERG in Primary Open Angle Glaucoma

> **NCT04422743** · NA · TERMINATED · sponsor: **Fondazione IRCCS Policlinico San Matteo di Pavia** · enrollment: 63 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DIETARY_SUPPLEMENT:** Citicoline 500 mg plus Homotaurine 50 mg

## Key facts

- **NCT ID:** NCT04422743
- **Lead sponsor:** Fondazione IRCCS Policlinico San Matteo di Pavia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-01-25
- **Primary completion:** 2020-09-11
- **Final completion:** 2020-09-11
- **Target enrollment:** 63 (ACTUAL)
- **Why stopped:** due to covid 19 pandemy
- **Last updated:** 2025-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04422743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04422743, "Effect of Citicoline/Homotaurine on PERG in Primary Open Angle Glaucoma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04422743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*